Articles

A new study in animals demonstrates that a diet rich in coconut oil protects against ‘insulin resistance’ (an impaired ability of cells to respond to insulin) in muscle and fat. The diet also avoids the accumulation of body fat caused by other high fat diets of similar calorie content.

In a bid to ramp up the public health battle against obesity, a group of nutrition and economics experts are pushing for a tax of 1 cent on every of ounce of sodas and other sweetened beverages.

Generex Biotechnology Corporation, an innovator for drug delivery for metabolic diseases through the inner lining of the mouth, announced that the U.S. FDA has granted approval for the treatment use of Oral-lyn™ under the FDA’s Treatment Investigational New Drug (IND) program.

In patients with recent onset Type 2 diabetes, treatment with insulin or the diabetes drug metformin did not reduce inflammatory biomarkers, such as high-sensitivity C-reactive protein, although the treatment did improve glucose control, according to a study.

Patients taking a novel diet drug that combines the stimulant phentermine with the anticonvulsant, topiramate lost an average of 37 pounds over a year with significant improvement in a number of cardiovascular risk factors.

We reviewed this information just a couple of weeks ago, but it is important enough to take another look at the results.

Men and women with smaller thighs have an increased risk for heart disease and early death compared with those with larger thighs, according to results of a large cohort study.

An international consortium of scientists has identified a new genetic variant associated with Type 2 diabetes, insulin resistance, and hyperinsulinemia , Dr. Johan Rung Cambridge, UK, and colleagues report.

An elevated fasting glucose level at hospital admission among patients with acute coronary syndrome (ACS) is associated with increased risk of death and other cardiovascular events up to 6 months later, U.S. researchers report.

The widespread recommendation for the routine use of low-dose aspirin in primary prevention of cardiovascular events for all patients with Type 2 diabetes should be revisited, experts said at theEuropean Society of Cardiology 2009 Congress.